MicroRNA-532 protects the heart in acute myocardial infarction, and represses prss23, a positive regulator of endothelial-to-mesenchymal transition
Open Access
- 11 July 2017
- journal article
- research article
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 113 (13) , 1603-1614
Abstract
Acute myocardial infarction (MI) leads to cardiac remodelling and development of heart failure. Insufficient myocardial capillary density after MI is considered a critical determinant of this process. MicroRNAs (miRs), negative regulators of gene expression, have emerged as important players in MI. We previously showed that miR-532-5p (miR-532) is up-regulated by the β-arrestin-biased β-adrenergic receptor antagonist (β-blocker) carvedilol, which activates protective pathways in the heart independent of G protein-mediated second messenger signalling. Here, we hypothesize that β2-adrenergic receptor/β-arrestin-responsive miR-532 confers cardioprotection against MI. Using cultured cardiac endothelial cell (CEC) and in vivo approaches, we show that CECs lacking miR-532 exhibit increased transition to a fibroblast-like phenotype via endothelial-to-mesenchymal transition (EndMT), while CECs over-expressing miR-532 display decreased EndMT. We also demonstrate that knockdown of miR-532 in mice causes abnormalities in cardiac structure and function as well as reduces CEC proliferation and cardiac vascularization after MI. Mechanistically, cardioprotection elicited by miR-532 is in part attributed to direct repression of a positive regulator of maladaptive EndMT, prss23 (a protease serine 23) in CECs. In conclusion, these findings reveal a pivotal role for miR-532-prss23 axis in regulating CEC function after MI, and this novel axis could be suitable for therapeutic intervention in ischemic heart disease.Keywords
Funding Information
- National Institutes of Health (R01 HL086555)
- National Institutes of Health (R01 HL124248)
- National Institutes of Health (R01 HL134354, AR070029)
- National Institutes of Health (R01 HL112640, HL126949, 12GRNT12100048)
- National Institutes of Health (R01 HL124251)
This publication has 55 references indexed in Scilit:
- Human MicroRNA miR-532-5p Exhibits Antiviral Activity against West Nile Virus via Suppression of Host Genes SESTD1 and TAB3 Required for Virus ReplicationJournal of Virology, 2016
- Characterization of Gene Expression Patterns among Artificially Developed Cancer Stem Cells Using Spherical Self-Organizing MapCancer Informatics, 2016
- miRNA‐532‐5p functions as an oncogenic microRNA in human gastric cancer by directly targeting RUNX3Journal of Cellular and Molecular Medicine, 2015
- Identification of gene signatures regulated by carvedilol in mouse heartPhysiological Genomics, 2015
- The emerging role of microRNAs in cardiovascular diseaseJournal of Internal Medicine, 2014
- MicroRNA-133 Modulates the β1-Adrenergic Receptor Transduction CascadeCirculation Research, 2014
- Profiling of Circulating MicroRNAs Reveals Common MicroRNAs Linked to Type 2 Diabetes That Change With Insulin SensitizationDiabetes Care, 2014
- Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5′ UTR as in the 3′ UTRProceedings of the National Academy of Sciences, 2007
- Coronary artery flow velocity profile measured by transthoracic Doppler echocardiography predicts myocardial viability after acute myocardial infarctionHeart, 2007
- The Forkhead Box m1 Transcription Factor Stimulates the Proliferation of Tumor Cells during Development of Lung CancerCancer Research, 2006